The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ignatyeva V.I.

National Medical Research Centre for Therapy and Preventive Medicine

Kontsevaya A.V.

National Medical Research Center for Therapy and Preventive Medicine

Kalinina A.M.

National Medical Research Center for Therapy and Preventive Medicine

Drozdova L.Yu.

National Medical Research Center for Therapy and Preventive Medicine

Mukaneeva D.K.

National Medical Research Center for Therapy and Preventive Medicine

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry

Socio-economic efficiency of the early cancer detection during the medical checkup

Authors:

Ignatyeva V.I., Kontsevaya A.V., Kalinina A.M., Drozdova L.Yu., Mukaneeva D.K., Drapkina O.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(1): 36‑44

Read: 2029 times


To cite this article:

Ignatyeva VI, Kontsevaya AV, Kalinina AM, Drozdova LYu, Mukaneeva DK, Drapkina OM. Socio-economic efficiency of the early cancer detection during the medical checkup. Russian Journal of Preventive Medicine. 2024;27(1):36‑44. (In Russ.)
https://doi.org/10.17116/profmed20242701136

Recommended articles:
Specifics of cancer dete­ction at the outpatient stage. A case report. Russian Journal of Preventive Medi­cine. 2024;(10):97-100
Impact of various reha­bilitation programs on anxiety and depression after surgery of early-stage cervical cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):40-44
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83

References:

  1. Rossijskij statisticheskij ezhegodnik. 2022: Statisticheskij sbornik. Rosstat. R76. M. 2022. (In Russ.).
  2. GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990—2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396 (10258):1204-1222. Erratum in: Lancet. 2020;396(10262):1562. https://doi.org/10.1016/S0140-6736(20)30925-9
  3. Federal’nyj proekt «Bor’ba s onkologicheskimi zabolevaniyami». Accessed July 18, 2023. (In Russ.). https://minzdrav.gov.ru/poleznye-resursy/natsproektzdravoohranenie/onko
  4. Rasporyazhenie Pravitel’stva Rossijskoj Federacii ot 12.10.2019 g. №2406-r (red. ot 06.10.2022 g.) «Ob utverzhdenii perechnya zhiznenno neobhodimyh i vazhnejshih lekarstvennyh preparatov, a takzhe perechnej lekarstvennyh preparatov dlya medicinskogo primeneniya i minimal’nogo assortimenta». Accessed July 18, 2023. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_335635
  5. Postanovlenie Pravitel’stva Rossijskoj Federacii ot 28.12.2021 g. №2505 «O Programme gosudarstvennyh garantij besplatnogo okazaniya grazhdanam medicinskoj pomoshchi na 2022 god i na planovyj period 2023 i 2024 godov». Accessed July 18, 2023. (In Russ.). https://static.government.ru/media/files/de3NXxmFdnBk5LLok0KHjVaKd7aw67Ul.pdf
  6. Prikaz Ministerstva zdravoohraneniya Rossijskoj Federacii ot 13.03.2019 g. №124n «Ob utverzhdenii poryadka provedeniya profilakticheskogo medicinskogo osmotra i dispanserizacii opredelennyh grupp vzroslogo naseleniya». Accessed July 18, 2023. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_323471/
  7. Kontsevaya AV, Kalinina AM, Boytsov SA, Ipatov PV. Socio-economic effectiveness of health screening activity in 2013 in Russian Federation. Kardiovaskuljarnaja terapija i profilaktika. 2014;13(3):4-10. (In Russ.). https://doi.org/10.15829/1728-8800-2014-3-4-10
  8. Prikaz Ministerstva zdravoohraneniya Rossijskoj Federacii ot 10.11.2020 g. №1207n «Ob utverzhdenii uchetnoj formy medicinskoj dokumentacii №131/u «Karta ucheta profilakticheskogo medicinskogo osmotra (dispanserizacii)», poryadka ee vedeniya i formy otraslevoj statisticheskoj otchetnosti №131/o «Svedeniya o provedenii profilakticheskogo medicinskogo osmotra i dispanserizacii opredelennyh grupp vzroslogo naseleniya», poryadka ee zapolneniya i srokov predstavleniya» (Zaregistrirovano v Minyuste Rossii 11.01.2021 №62033). Accessed July 18, 2023. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_373766/
  9. Ignatieva VI, Gretsova OP, Stenina MB, et al. Socio-economic burden of breast cancer in the Russian Federation. Medicinskie tehnologii. Ocenka i vybor. 2016;4(26):32-49. (In Russ.).
  10. Klinicheskie rekomendacii. Rak shejki matki. Odobreno Nauchno-prakticheskim Sovetom Ministerstva zdravoohraneniya Rossijskoj Federacii. 2020. Accessed July 18, 2023. (In Russ.). https://cr.minzdrav.gov.ru/recomend/537_1
  11. Klinicheskie rekomendacii. Rak pryamoj kishki. 2022. Odobreno na zasedanii nauchno-prakticheskogo soveta Ministerstva zdravoohraneniya Rossijskoj Federacii. Accessed July 18, 2023. (In Russ.). https://cr.minzdrav.gov.ru/recomend/554
  12. Klinicheskie rekomendacii. Zlokachestvennye novoobrazovaniya obodochnoj kishki i rektosigmoidnogo otdela. 2020. Odobreno nauchno-prakticheskim sovetom Ministerstva zdravoohraneniya Rossijskoj Federacii. Accessed July 18, 2023. (In Russ.). https://cr.minzdrav.gov.ru/recomend/396_1
  13. Sostoyanie onkologicheskoǐ pomoshchi naseleniyu Rossii v 2019 godu. Pod red. Kaprina A.D., Starinskogo V.V., Shahzadovoj A.O. M.: MNIOI im. P.A. Gercena — filial FGBU «NMIC radiologii» Minzdrava Rossii; 2020. (In Russ.).
  14. Ruan WC, Che YP, Ding L, Li HF. Efficacy and Toxicity of Addition of Bevacizumab to Chemotherapy in Patients with Metastatic Colorectal Cancer. Combinatorial Chemistry and High Throughput Screening. 2018;21(10):718-724.  https://doi.org/10.2174/1386207322666190119162352
  15. Tewari KS, Sill MW, Penson RT, et al. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet. 2017;390(10103):1654-1663. https://doi.org/10.1016/S0140-6736(17)31607-0
  16. Metodicheskie rekomendacii po sposobam oplaty medicinskoj pomoshchi za schet sredstv obyazatel’nogo medicinskogo strahovaniya (utv. Ministerstvom zdravoohraneniya RF i Federal’nym fondom obyazatel’nogo medicinskogo strahovaniya 2 fevralya 2022 g. №№11-7/I/2-1619, 00-10-26-2-06/750). Accessed July 18, 2023. (In Russ.). https://www.ffoms.gov.ru/documents/the-orders-oms/
  17. Obnovlennaya rasshifrovka kliniko-statisticheskih grupp zabolevanij s uchetom osobennostej okazaniya medicinskoj pomoshchi, opredelennyh Prikazom №344n. Accessed July 18, 2023. (In Russ.). https://www.ffoms.gov.ru/documents/the-orders-oms/
  18. Prikaz Ministerstva truda i social’noj zashchity Rossijskoj Federacii ot 27 avgusta 2019 g. №585n «O klassifikaciyah i kriteriyah, ispol’zuemyh pri osushchestvlenii mediko-social’noj ekspertizy grazhdan federal’nymi gosudarstvennymi uchrezhdeniyami mediko-social’noj ekspertizy». Accessed July 18, 2023. (In Russ.). https://www.consultant.ru/document/cons_doc_LAW_337846/
  19. Srednij razmer naznachennyh pensij invalidov, sostoyashchih na uchete v sisteme Pensionnogo fonda Rossijskoj Federacii. Accessed July 18, 2023. (In Russ.). https://rosstat.gov.ru/folder/13964
  20. Guide to calculating national life tables — Office for National Statistics. Accessed July 18, 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/methodologies/guidetocalculatingnationallifetables
  21. Mendrina GI, Olejnichenko VF. Metodika postroeniya i analiza tablic smertnosti, opredeleniya srednej prodolzhitel’nosti predstoyashchej zhizni. Uchebnoe posobie. T.: Sibirskij gosudarstvennyj medicinskij universitet; 2008. (In Russ.).
  22. Centr demograficheskih issledovanij Rossijskoj ekonomicheskoj shkoly. Koefficienty smertnosti po vozrastu i polu. Rossiya i regiony, odnoletnie vozrastnye gruppy, 2015—2021 gg. Accessed July 18, 2023. (In Russ.). https://demogr.nes.ru/index.php/ru/demogr_indicat/data
  23. Rabochaya sila, zanyatost’ i bezrabotica v Rossii (po rezul’tatam vyborochnyh obsledovanij rabochej sily). 2022. Statistical book. M.: Rosstat, 2022. (In Russ.).
  24. Merabishvili VM. Zlokachestvennye novoobrazovaniya v Severo—Zapadnom federal’nom okruge Rossii (zabolevaemost’, smertnost’, dostovernost’ ucheta, vyzhivaemost’ bol’nyh). Pod red. Belyaeva A.M. Ekspress-informaciya. Vypusk shestoj. Posobie dlya vrachej. SPb. 2023. (In Russ.).
  25. Office for National Statistics. Dataset. Cancer survival in England — adults diagnosed. 2013—2017 edition. Accessed July 18, 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancersurvivalratescancersurvivalinenglandadultsdiagnosed
  26. Kliniko-ekonomicheskij analiz. Pod red. Vorob’eva P.A. M.: N’yudiamed; 2008. (In Russ.).
  27. Pravila formirovaniya perechnej lekarstvennyh preparatov dlya medicinskogo primeneniya i minimal’nogo assortimenta lekarstvennyh preparatov, neobhodimyh dlya okazaniya medicinskoj pomoshchi. Utverzhdeny Postanovleniem Pravitel’stva Rossijskoj Federacii №871 ot 28 avgusta 2014 g. Accessed July 18, 2023. (In Russ.). https://base.consultant.ru/cons/cgi/online.cgi?req=doc;base=LAW;n=167999
  28. Teptsova TS, Musina NZ, Omelyanovsky VV. Evaluation of the reference value of the incremental parameter «cost-effectiveness» for Russian healthcare system. Farmakojekonomika. Sovremennaja farmakojekonomika i farmakojepidemiologija. 2020;13(4):367-376. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.071
  29. Kotenko ON, Omelyanovsky VV, Ignatieva VI, et al. The cost of chronic kidney disease in the Russian Federation. Klinicheskaya nefrologiya. 2021;4:30-38. (In Russ.). https://doi.org/10.18565/nephrology.2021.4.30-38
  30. Mezei AK, Armstrong HL, Pedersen HN, et al. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review. International Journal of Cancer. 2017;141(3):437-446.  https://doi.org/10.1002/ijc.30695
  31. Khalili F, Najafi B, Mansour-Ghanaei F, et al. Cost-Effectiveness Analysis of Colorectal Cancer Screening: A Systematic Review. Risk Management and Healthcare Policy. 2020;13:1499-1512. https://doi.org/10.2147/RMHP.S262171
  32. Mühlberger N, Sroczynski G, Gogollari A, et al. Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care. 2021;22(8):1311-1344. https://doi.org/10.1007/s10198-021-01338-5
  33. Munshi VN, Perkins RB, Sy S, Kim JJ. Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. American Journal of Obstetrics and Gynecology. 2022;226(2):228.e1-228.e9.  https://doi.org/10.1016/j.ajog.2021.09.012

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.